Supplementary Material: Real-world assessment of response to anti-PD-1 therapy in advanced cutaneous squamous cell carcinoma

Published: 19 January 2021| Version 1 | DOI: 10.17632/g769x5dt5r.1
Contributor:
Sophia Shalhout

Description

Supplementary Material: Real-world assessment of response to anti-PD-1 therapy in advanced cutaneous squamous cell carcinoma Supplemental Detailed Methods Supplemental Table 1 Supplemental Figure 1

Files

Institutions

Harvard Medical School, Massachusetts General Hospital Cancer Center

Categories

Immunotherapy, Outcomes Research, Squamous Cell Carcinoma, Non-Melanoma Skin Cancer, Programmed Death-Ligand 1

Licence